A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese
about
A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in JapaneseMethods of integrating data to uncover genotype-phenotype interactions.VAV3 mediates resistance to breast cancer endocrine therapy.2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.PharmGKB summary: tamoxifen pathway, pharmacokineticsPharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis.Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in Chinese population.Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyPrediction of breast cancer survival using clinical and genetic markers by tumor subtypes.Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era.Personalized medicine: is it a pharmacogenetic mirage?Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerGenome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.Implications of genome-wide association studies in cancer therapeuticsPharmacogenetics of chemotherapy efficacy in breast cancer.Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies.CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis.Pharmacogenomics toward personalized tamoxifen therapy for breast cancer.Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction.Breast cancer: The translation of big genomic data to cancer precision medicine.Highlights from the latest pharmacogenomic genome-wide association studies.Rethinking ovarian cancer genomics: where genome-wide association studies stand?Impact of four loci on serum tamsulosin hydrochloride concentration.Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.
P2860
Q28943445-A49686A8-7CD8-4642-8E03-C52139F436D2Q30884207-54C7680D-D497-48E2-8F8F-87C590EE9D85Q33827037-87EE5673-33EA-4C20-B60C-401F72F654E1Q33848895-2F151E34-E196-49A7-8A39-7218983518CAQ33855494-AC194596-8508-438F-9F61-E4A561BECA31Q34307589-1B669049-53C5-4027-9474-F814A29AA294Q34526153-B57AAFDA-BE4A-4493-AF8D-87D6011CF755Q34671809-297C40A1-F952-49F6-A729-385138A13A29Q35009604-6A53F4AB-BF58-4C5A-ACAE-3CB962F78564Q35106676-18B0918B-2321-4E3F-BD0D-59E67063A99DQ35218520-68721511-FA10-4518-9FEA-A3C5BCE581BBQ35389904-9DAD670D-FA4F-4BDB-8AE0-90A8715A680EQ36071595-3D9AB7F4-9AB5-4CDF-B812-84FF018740B8Q36203536-63F18618-41E2-464D-84B9-83B1EACE4FFDQ36336007-FDB5988D-1C9B-4781-A1E6-652B90315D17Q36916243-41B83F7F-CC57-49C8-A42A-FC43E0FDF10DQ36950502-568F659A-3AB2-4568-ABDF-B4B779EC6178Q37161892-AD0B34A0-2868-4602-86B7-909BC5B11F95Q38003703-BF66A4BD-0155-48D1-BB0B-18C15FDEBBF2Q38105253-009136F6-9929-43F6-9F54-95AF0825FF4EQ38109822-7D7F5BF0-073B-4AE3-88BA-E897F3D13A0CQ38364888-D51B93FB-CB3F-43D1-A735-C9B61BCCF530Q38513661-CA19C3BA-A353-4987-853B-C94D13D87C0FQ38613552-2B2FE0BC-93D9-4D94-8656-217C3D0E86A3Q43843244-4A58F91C-8CA0-4004-9891-1D14B2A47773Q45943221-D9C45D3C-EF7E-4991-AEBF-047846ED16AAQ46518742-77610332-B5A2-4DA2-8387-1623002D0681Q47592913-788C3FFD-AC68-4340-BDA1-5D07C367F5F1Q49048955-97EF6A83-F31A-4EC6-8C7B-5617B7D40007Q49252742-2FF74389-A1A7-46E4-9F02-468AA810E04F
P2860
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese
description
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im April 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2012/04/01)
@nl
наукова стаття, опублікована у квітні 2012
@uk
مقالة علمية (نشرت في أبريل 2012)
@ar
name
A genome-wide association stud ...... st cancer patients in Japanese
@ast
A genome-wide association stud ...... st cancer patients in Japanese
@en
type
label
A genome-wide association stud ...... st cancer patients in Japanese
@ast
A genome-wide association stud ...... st cancer patients in Japanese
@en
prefLabel
A genome-wide association stud ...... st cancer patients in Japanese
@ast
A genome-wide association stud ...... st cancer patients in Japanese
@en
P2093
P2860
P356
P1476
A genome-wide association stud ...... st cancer patients in Japanese
@en
P2093
Chiyo K. Imamura
Fuminori Aki
Hitoshi Zembutsu
Kazuma Kiyotani
Koichi Hirata
Michiaki Kubo
Minoru Okazaki
Mitsunori Sasa
Naoya Hosono
Shozo Ohsumi
P2860
P304
P356
10.1093/HMG/DDR597
P577
2012-04-01T00:00:00Z